17/05/2024  15:11:43 Var. - Volume Denaro17:35:12 Lettera17:35:12 Capitalizzazione di mercato Dividend Y. Rapporto P/E
120.20EUR - 108
Fatturato: 13,071.20
-Quantità in denaro: - -Quantità in lettera: - 302.49 bill.EUR - -

Descrizione business

Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through its prescription medicines, vaccines, biologic therapies and animal health products, the company works with customers and operate in more than 140 countries to deliver innovative health solutions. Merck also demonstrates its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Robert M. Davis
Consiglio di amministrazione
Caroline Litchfield, Sanat Chattopadhyay, Richard R. DeLuca, Jr., Cristal N. Downing, Michael A. Klobuchar, Jannie Oosthuizen, Joseph Romanelli, Dave Williams, Jennifer Zachary, Dean Y. Li, M.D., Ph.D., Chirfi Guindo, Betty Larson
Consiglio di sorveglianza
Robert M. Davis, Thomas H. Glocer, Risa J. Lavizzo-Mourey, M.D., Stephen L. Mayo, Ph.D., Paul B. Rothman, M.D., Patricia F. Russo, Christine E. Seidman, M.D., Inge G. Thulin, Kathy J. Warden, Peter C. Wendell, Mary Ellen Coe, Pamela J. Craig, Douglas M. Baker
 

Dati aziendali

Name: Merck & Co. Inc.
Indirizzo: 126 East Lincoln Avenue,Rahway, NJ 07065 USA
Telefono: +1-908-740-4000
Fax: -
E-mail: -
Internet: www.merck.com
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 83.84%
Data dell'IPO: -

Rapporti con gli investitori

Name: -
IR telefono: +1-732-594-1468
IR Fax: -
IR e-mail: investor_relations@merck.com

Company calendar

CW 22 | 28/05/2024 General Shareholder Meeting
CW 31 | 30/07/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 31/10/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
64.78%
Vanguard Group Inc
 
9.66%
Blackrock Inc.
 
7.97%
State Street Corp
 
4.61%
Wellington Management Group Llp
 
3.38%
Geode Capital Management, Llc
 
2.19%
Fmr Llc
 
1.69%
Morgan Stanley
 
1.58%
Bank Of America Corp /De/
 
1.50%
Altri
 
2.64%